PYCXF Stock Latest News
Company AnnouncementsPYC Therapeutics Issues New Shares After Option Exercise, Confirms Regulatory Compliance2d ago
Company AnnouncementsPYC Therapeutics Seeks ASX Quotation for 540,000 New Shares2d ago
Company AnnouncementsPYC Therapeutics Advances Multi-Program RNA Pipeline With New Clinical Data in Q3 20263d ago
Company AnnouncementsPYC Therapeutics Showcases Early PKD Trial Data for PYC-003 at ASN Meeting1w ago
Company AnnouncementsPYC Therapeutics Confirms Lapse of 100,000 Options3w ago
Company AnnouncementsPYC to unveil early efficacy signals for PKD drug PYC-003 at ASN3w ago
Company AnnouncementsPYC Therapeutics Updates Investors, Emphasizes Early-Stage Status and Risks1M ago- Company AnnouncementsPYC Therapeutics to Showcase ADOA Drug Data at NOSA 20261M ago
- Company AnnouncementsRetail Employees Super Fund Exits Substantial Holding in PYC Therapeutics2M ago
- Company AnnouncementsPYC Therapeutics Reports Positive Early Safety Data for PKD Drug PYC-0032M ago
Company AnnouncementsPYC details evolving governance framework aligned with ASX principles2M ago
- Company AnnouncementsPYC Therapeutics Narrows Loss and Strengthens Balance Sheet in FY20262M ago
Company AnnouncementsPYC Therapeutics Schedules September Investor Webinar to Detail Pipeline Progress2M ago- Company AnnouncementsPYC Therapeutics boosts CEO equity incentives with major option and rights grants2M ago
Company AnnouncementsPYC Therapeutics advances genetic disease pipeline and strengthens corporate footing3M agoCompany AnnouncementsPYC Therapeutics Secures Shareholder Approval at Extraordinary General Meeting3M ago